Anti - HCV - immunoassay testing
Active Purchase Order Awarded Last action
- Contract number
- W81K0022P0154
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,339,136
Award facts
- Opportunity
-
- Sources Sought Notice – Cost-Per-Test- Immunoassay Testing Pre-Solicitation · W81K0022Q0104 · Posted Mar 31, 2022
- Contract value 80% obligated
- $1,664,718.13 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | -$37,502 | |
| Funding Only Action | -$61,616 | |
| Funding Only Action | $384,114 | |
| Funding Only Action | -$121,899 | |
| Funding Only Action | -$42,626 | |
| Exercise an Option | $0 | |
| Funding Only Action | $384,114 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $356,664 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $36,495 | |
| Supplemental Agreement for work within scope | $17,752 | |
| Funding Only Action | $338,912 | |
| Exercise an Option | $0 | |
| Original award | $84,728 |
Show all 19
About this award
The Defense Health Agency awarded a purchase order to Abbott Laboratories Inc., Abbott Diagnostics Division, on July 1, 2022, for anti-HCV immunoassay testing and transfer of administrative responsibilities for immunoassays and reagents, with a ceiling value of $1,664,718.13.
Work is performed at Abbott's facility in North Chicago, Illinois. The order is firm fixed price with no set-aside applied. Ultimate completion is September 30, 2027. The procurement originated from a pre-solicitation notice issued March 31, 2022, by the Regional Health Contracting Office – Central on behalf of the San Antonio Military Medical Center, seeking capability statements for immunoassay testing services including hepatitis antibodies and antigens, anti-thyroglobulin and anti-thyroid peroxidase antibodies, and tacrolimus assays across fiscal years 2022 through 2026.
Quick answers
Who was awarded contract W81K0022P0154?
W81K0022P0154 was awarded to Abbott Laboratories Inc. by Medical Command (Department of the Army) on July 1, 2022.
How much is contract W81K0022P0154 worth?
The government has obligated $1,339,136 on W81K0022P0154. Its current value, with exercised options, is $1,664,718.
Which agency awarded contract W81K0022P0154?
Medical Command (Department of the Army) awarded W81K0022P0154, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0022P0154 competed?
The extent of competition for W81K0022P0154 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award